Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer

Figure 7

K-M curves for the progression-free survival of sufferers in the high and low groups based on the mean expression of (a) HOXA2, (b) HOXA3, (c) HOXA6, (d) HOXA10, and (e) HOXA13 in TCGA cohort.

(a)

(b)

(c)

(d)

(e)